2025-02-25 - Analysis Report
## Intuitive Surgical Inc. (ISRG) Stock Report

**0. Key Figures & Initial Analysis:**

ISRG, Intuitive Surgical Inc., is a leading developer and manufacturer of robotic surgery systems.  The company has significantly outperformed the S&P 500 (VOO) over the provided period.

**1. Performance Comparison vs. S&P 500 (VOO):**

* **ISRG Cumulative Return:** 328.35%
* **VOO Cumulative Return:** 117.28%
* **Return Difference:** 211.07% (Significantly higher than VOO)
* **Relative Divergence:** 94.6% (indicates ISRG's performance is in the top 94.6% percentile relative to its historical performance vs. VOO)

The provided alpha and beta analysis shows high CAGR (Compound Annual Growth Rate) across various periods, suggesting strong historical performance, while the beta values fluctuate, suggesting varying levels of market correlation over time.  The high alpha values in the last few years (1.0 and 0.8) suggest significant outperformance compared to the market benchmark.  However, note that past performance is not indicative of future results.

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2015-2017  | 77.0% | 7.3% | 49.0% | -0.0 | 43.4 |
| 2016-2018  | 89.0% | 8.9% | 71.0% | 0.0 | 56.9 |
| 2017-2019  | 93.0% | 9.8% | 63.0% | 0.5 | 70.3 |
| 2018-2020  | 71.0% | 9.8% | 43.0% | 0.2 | 97.3 |
| 2019-2021  | 113.0% | 9.8% | 42.0% | 0.2 | 128.2 |
| 2020-2022  | 21.0% | 20.6% | 12.0% | 0.2 | 94.6 |
| 2021-2023  | 19.0% | 20.6% | -4.0% | 1.0 | 120.3 |
| 2022-2024  | 128.0% | 20.4% | 95.0% | 1.0 | 186.2 |
| 2023-2025  | 222.0% | 9.9% | 164.0% | 0.8 | 210.8 |


**2. Recent Price Movement:**

* **Closing Price:** $591.01
* **Previous Close:** $591.79
* **5-Day Moving Average:** $599.75
* **20-Day Moving Average:** $587.78
* **60-Day Moving Average:** $561.15

The price is currently below its 5-day and 20-day moving averages, suggesting a short-term downtrend. However, it's above the 60-day moving average, indicating a longer-term upward trend.  The recent price change shows a minor decrease (-$0.78).

**3. Technical Indicators:**

* **RSI:** 58.26 (Neither overbought nor oversold; suggests neutral momentum)
* **PPO:** -0.19 (Negative, indicating bearish momentum)
* **Recent Relative Strength Change (20-day):** 0.6 (+), suggesting short-term upward momentum.  This is contradicted somewhat by the negative PPO.
* **Expected Return (2+ years):** 19.5% (significantly higher than the S&P 500 implied return).


**4. Recent Earnings Analysis:**

The recent earnings show a relatively stable EPS (Earnings Per Share) and steadily increasing revenue, though there's a slight dip in Q4 2023.  The data is duplicated for 2024-10-18.  Cleaning the duplicated entry and analyzing the trend, revenue has been consistently increasing.

| Date       | EPS  | Revenue     |
|------------|------|-------------|
| 2024-10-18 | 1.59 | $2.04 B     |
| 2024-07-19 | 1.48 | $2.01 B     |
| 2024-04-19 | 1.54 | $1.89 B     |
| 2023-10-20 | 1.18 | $1.74 B     |


**5. Financial Information:**

Both revenue and profit margins have been consistently high and stable over the last few quarters, demonstrating the company's financial strength.  Equity is also increasing steadily, while ROE (Return on Equity) shows some fluctuation but generally remains positive.

**Revenue and Profitability:**

| Quarter     | Revenue  | Profit Margin |
|-------------|----------|---------------|
| 2024-12-31 | $2.41B   | 68.04%        |
| 2024-09-30 | $2.04B   | 67.41%        |
| 2024-06-30 | $2.01B   | 68.30%        |
| 2024-03-31 | $1.89B   | 65.87%        |
| 2023-12-31 | $1.93B   | 66.24%        |

**Capital and Profitability:**

| Quarter     | Equity    | ROE     |
|-------------|-----------|---------|
| 2024-12-31 | $16.43B   | 4.17%   |
| 2024-09-30 | $15.58B   | 3.63%   |
| 2024-06-30 | $14.71B   | 3.58%   |
| 2024-03-31 | $13.96B   | 3.90%   |
| 2023-12-31 | $13.31B   | 4.56%   |


**6. Overall Analysis:**

ISRG shows strong historical performance, significantly outperforming the S&P 500.  Recent financial data suggests robust revenue growth and high profitability. While short-term indicators show some bearish signals, the long-term outlook remains positive given the consistent growth in revenue, and the predicted high future return. However,  investors should be aware of the inherent risks in the market and consider diversification. The high valuation and dependence on a single product line represent potential downside risks.  Further due diligence is recommended before making any investment decisions.
